The Total Artificial Heart market size is expected to grow significantly over the forecast period. The market held a market value of USD 1.2 billion and will register a 22.5% CAGR in terms of revenue in 2026.
Total Artificial Heart Market Overview
Increase in the burden of cardiovascular diseases along with increase in mortality rate of geriatric population is boosting the demand for artificial heart. According to WHO, nearly 18 million people die every year due cardiovascular diseases which accounts for 31% of worldwide deaths. Reasons for CVD are smoking, tobacco, alcohol consumption and unbalanced diet. Hence, increase in CVD is expected to fuel the market for artificial heart. According to WHO, population of people aged 60 years and above is expected to rise from 900 million in 2015 to 2 billion in the year 2050 which in turn will increase the CVD problems and growth in the market for artificial heart. Rise in population of patients with end-stage heart failure, including congestive heart failure along with rarity of transplants available is a major factor driving the market for artificial heart. Artificial heart plays an important role in managing end-stage heart failure in the patient population. Artificial heart in emerging as feasible option for patients with acute biventricular dysfunction.
Who are the Major Players in An Artificial Heart Market?
Top Key Players in the Artificial Heart Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Artificial Heart Market is fragmented with a large number of small players operating worldwide. The companies referred to in the market research report include BiVACOR, SynCardia, Jarvik Heart, Carmat SA (Paris :ALCAR.PA), AbioMed and others.
Industry News-
Artificial heart co. Bivacor nabs $22M in Series B, grant funding
May 19, 2021- Bivacor, which is developing an artificial heart medical device, announced the $19 million in Series B funding on May 19. The Series B raise was led by Boston-based Cormorant Asset Management and Australian venture capital firm OneVentures. Additionally, Bivacor has received $3 million in Small Business Innovation Research grant funding from the National Heart, Lung, and Blood Institute at the U.S. National Institute of Health.
What are the major Applications, Types, and Regions of the Total Artificial Heart Market?
Total Artificial Heart Market is segmented based on the type, applications, companies and regions.
Type-
Application-
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
Regional Analysis-
The Americas is the market forerunner and has an eye-catching market for artificial heart owing to the increasing occurrence of cardiovascular, neurological, and other infections affecting to the increasing geriatric population, which is a major trigger factor. Permitting to the Center for Disease Control and Prevention over 620,000 Americans die from heart diseases every year, which accounts for one in every four deaths. Thus, numerous major companies are in a race for the overview of high-quality strategies and accessories for better organization of data for patients with CVD.
Moreover, according to the US Census Bureau, around 48.3 million residents were aged 60 and above. This huge older population led to over 14.2% of the total population, which is probable to drive the market. Besides, the Americas is perceiving rampant developments in technology, and cumulative government initiatives, and funding for research in the medical devices sector is driving the market growth.
The report offers in-depth assessment of the growth and other aspects of the Total Artificial Heart Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
What is our Total Artificial Heart Market report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2021-2026. The report presents the analysis of Total Artificial Heart Market for the historical period of 2017-2021 and the forecast period of 2021-2026.
Reports Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 22.5% during the review period (2022 to 2027).
|
By Type
|
|
By Application
|
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
|
By Companies
|
BiVACOR, SynCardia, Jarvik Heart, Carmat SA (Paris :ALCAR.PA)
|
Regions Covered
|
• North America
• Europe
• Asia-Pacific
• Rest of the World
|
Countries Covered
|
• US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Middle East & Africa
• Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
93
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Total Artificial Heart Report
- Evaluate Total Artificial Heart market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.
- Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
- Analyze the sales and distribution channels across key geographies to improve top-line revenues.
- Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Total Artificial Heart market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
Frequently Asked Questions
What is the study period of this market?
The Total Artificial Heart Market is studied from 2017 - 2027.
Who are the key players in Total Artificial Heart Market?
BiVACOR, SynCardia, Jarvik Heart, Carmat SA (Paris :ALCAR.PA), AbioMed and others.
What are the significant types of Total Artificial Heart Market?
SynCardia, Others.
What are the major end-use applications of the Total Artificial Heart Market?
Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Others.
What segments are covered in the Total Artificial Heart Market report?
The Global Total Artificial Heart Market is Segmented on the basic of Product, Application, and Geography.
How can I get a sample report/company profile for the Total Artificial Heart Market?
The sample report for the Total Artificial Heart Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
